3136 results for «2900»
3136 results
Challenging session in calcified lesions
22 May 2025 – From EuroPCR 2025
Engage with a challenging session focused on complex calcified lesion interventions. Topics include innovative triple burr techniques, OCT insights into resistant lesions, volume reduction strategies, eccentric calcium management, and IVUS-guided left main calcified lesion treatment, highlighting practical approaches to difficult cases.
ACS management: when imaging matters
22 May 2025 – From EuroPCR 2025
This session focuses on the critical role of intracoronary imaging in acute coronary syndrome (ACS) management. Topics include spontaneous coronary artery dissection (SCAD) cases, the utilization of IVUS and cardiac CT in emergent PCI during cardiogenic shock, and the assessment of non-culprit lesions using OCT to...
Leaflet modification to prevent coronary obstruction during TAVI
22 May 2025 – From EuroPCR 2025
This session addresses advanced leaflet modification techniques to prevent coronary obstruction during TAVI. Learn from detailed cases involving valve-in-valve interventions, treatment of failed stentless valves, homograft management, and dedicated devices for leaflet modification prior to valve-in-valve and valve-in-valve-in-valve procedures.
Antiplatelet strategies for clinical dilemmas
22 May 2025 – From EuroPCR 2025
Dive into the complexities of antiplatelet strategies tailored for challenging clinical scenarios. This session covers antiplatelet therapy in myocardial bridge, bleeding risk reduction via ticagrelor removal before urgent CABG, peri-procedural management for patients on oral anticoagulants undergoing PCI, and the use of cangrelor in out-of-hospital cardiac...
Shock and PCI: due to ECMO I survived
22 May 2025 – From EuroPCR 2025
Explore life-saving strategies in the management of cardiogenic shock complicating PCI, with emphasis on ECMO utilization. This session reviews challenging cardiac arrest cases, multi-culprit STEMI scenarios, and innovative STEMI treatments in critical patients, illustrating how ECMO support can be pivotal in survival and recovery.
TAVI - Outcomes predictors
22 May 2025 – From EuroPCR 2025
Examine novel predictors of outcomes following TAVI. This session compares a new nutritional risk index against traditional scores for early post-TAVI mortality prediction and evaluates uric acid as a marker for aortic valve calcification and mortality risk in TAVI patients.
Artificial intelligence in the cathlab
22 May 2025 – From EuroPCR 2025
Delve into the transformative role of artificial intelligence (AI) in the cathlab. This session covers AI applications for vulnerable plaque identification using intracoronary OCT, automated coronary angiogram analysis, rapid AI-based OCT interpretation, AI-enhanced decision-making for PCI optimization, and noninvasive microvascular resistance assessment powered by AI.
Retrograde removal of the broken sheath
22 May 2025 – From EuroPCR 2025
This session addresses complex complications during vascular access with a focus on retrograde removal of broken sheaths. Learn to recognize critical signs, manage rare but severe complications including broken guidewires in the radial artery, and explore innovative off-label solutions for challenging scenarios.
Deep dive on pulmonary embolism catheter technologies - Clinical trial data and how to use
22 May 2025 – From EuroPCR 2025
Deep dive into pulmonary embolism catheter technologies through case-based presentations. Learn about established and novel devices for acute pulmonary embolism treatment, indications for device use, and management of procedural complications to optimize patient outcomes.
TAVI for aortic regurgitation off label
22 May 2025 – From EuroPCR 2025
Explore off-label applications of TAVI for aortic regurgitation in complex clinical scenarios. Topics include TAV-in-SAV with Trilogy valve for severe regurgitation, challenges of transcatheter prosthesis in pure aortic regurgitation, management of surgical valve perforations, and treatment strategies in post-surgical anatomies including degenerative homografts and aortic dissection.
Risk stratification of NSTEMI patients
22 May 2025 – From EuroPCR 2025
Explore the latest insights on risk stratification in NSTEMI patients through comparative analysis of established risk scores such as GRACE, HEART, and TIMI in predicting coronary artery disease severity. This session also reviews outcomes based on diabetes status and left ventricular ejection fraction, prospective validation of...
Acute complications during distal left main PCI - Part 3
22 May 2025 – From EuroPCR 2025
This session highlights acute complications during distal left main PCI. It presents cautionary cases of incorrect left main stenting, catastrophic left main V stenting outcomes, unprotected left main thrombosis, and survival strategies when new technologies fail unexpectedly.
Should STEMI treatment be related to specific clinical patient characteristics
22 May 2025 – From EuroPCR 2025
This session evaluates whether STEMI treatment should be tailored to specific clinical patient characteristics. It includes insights into STEMI management in very young patients, benefits of revascularisation of LAD non-culprit lesions in older AMI patients, clinical outcomes from the NAMI registry for young STEMI patients, and...
Understanding research: insights from a groundbreaking study
22 May 2025 – From EuroPCR 2025
Enhance your understanding of contemporary research in PCI versus CABG with this session. Learn foundational research principles, latest study findings, and how to translate evidence into clinical practice to improve patient communication and outcomes, bridging the gap between research and everyday cardiology care.
Emerging indications for TAVI in 2025
22 May 2025 – From EuroPCR 2025
Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.
High-risk PCI in acute coronary syndrome
22 May 2025 – From EuroPCR 2025
Explore high-risk PCI strategies in acute coronary syndrome patients who are unsuitable for surgery. This session presents insights on Killip class influence, haemodynamic support with micro-axial flow pumps, disease progression patterns in complicated STEMI, and the prognostic value of QFR-guided functional SYNTAX scores in ACS management.
Innovative approaches to refractory heart failure: devices and therapies to the rescue
23 May 2025 – From EuroPCR 2025
This session highlights innovative device-based therapies for refractory heart failure, emphasizing the integration of neuromodulation, decongestive strategies, and the synergy with pharmacological treatments. Case presentations illustrate the evolving landscape of advanced heart failure management.
Management of bifurcations with complex anatomy - part 2
23 May 2025 – From EuroPCR 2025
Explore advanced techniques for managing bifurcations with complex anatomy. This session covers novel guidewire penetration methods, cutting balloon fenestration for dissections, rotatripsy for calcified nodules, and precision wiring in challenging left anterior descending artery curves.
How coronary physiology may help in guiding treatment of NSTEMI
23 May 2025 – From EuroPCR 2025
This session explores the utility of coronary physiology in guiding NSTEMI treatment. Topics include ischemia with non-obstructive arteries, QFR quality assessment, FFR-CT impact, revascularization deferral, and sex differences in FFR-guided strategies for acute myocardial infarction with multivessel disease.
Permanent pacing after TAVI
23 May 2025 – From EuroPCR 2025
Explore predictors and mechanisms leading to permanent pacemaker implantation after TAVI. This session reviews electrophysiological intervals, atrial pacing markers, anatomical risk factors, and outcomes associated with new generation transcatheter heart valves.
